B&W (BW) 2022 EBITDA Revision Case

In October 2022, B&W unexpectedly revised 2022 EBITDA. 
On it, $BW fell 37%, losing $265M+ shareholder value. 
Investors may have grounds to suspect B&W of overstating its financial projections, which led to their losses.
On October 27, 2022, Babcock & Wilcox Enterprises (BW) revised full-year 2022 adjusted EBITDA, expecting $70 million to $80 million.
B&W attributed the reduction to the delay of revenue recognition on certain projects.
B&W listed the reasons for revenue reduction as geopolitical issues and the war in Ukraine.
On this news, $BW fell 37% and lost over $265 million of its market capitalization, seriously damaging shareholders.

Considering all the information, investors might have grounds to suspect that B&Ws and its executives overstated its financial projections, which consequently led to their losses.

The case is already under investigation by at least one of the reputable law firms.

Case Status

Attorney Investigation

Alleged Offence

Misleading Statements,

Financial Misrepresentation,

Failure to Disclose,

Omissions

Suspected Party

Directors,

Management

Security Type

Stocks

Trade Direction

Long

Shock Event Date

27 October 2022

B&W (BW) 2022 EBITDA Revision Case

Collecting participants…